WS #11551
Vertex Pharmaceuticals agrees to acquire Crinetics Pharmaceuticals for $85/share in cash, a significant M&A deal in biotech.
Vertex Acquires Crinetics Pharmaceuticals
Vertex Pharmaceuticals agrees to acquire Crinetics Pharmaceuticals for $85/share in cash, a significant M&A deal in biotech.